Name

Bexarotene

Alternate Names

LGD 1069
LGD-1069
LGD1069
Targretin

Abbreviations

None

Category

Chemotherapy

Subcategory

cytostatic agent--Retinoid X receptor agonist

NSC Number

None

Primary Site

Breast
colorectal
Cutaneous T-cell lymphoma
head & neck
kidney
lung

Histology

None

Remarks

Rexinoid, a selective retinoid X receptor (RXR) agonist. FDA approved therapy for cutaneous T-cell lymphoma. Is used off-label for lung and breast cancer, also Kaposi's sarcoma.

Coding

This drug should be coded
Glossary